BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34898375)

  • 1. The abnormal expression of chromosomal region maintenance 1 (CRM1)-survivin axis in ovarian cancer and its related mechanisms regulating proliferation and apoptosis of ovarian cancer cells.
    Zhang J; Xu X; Chen Y; Guan X; Zhu H; Qi Y
    Bioengineered; 2022 Jan; 13(1):624-633. PubMed ID: 34898375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.
    Noske A; Weichert W; Niesporek S; Röske A; Buckendahl AC; Koch I; Sehouli J; Dietel M; Denkert C
    Cancer; 2008 Apr; 112(8):1733-43. PubMed ID: 18306389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer.
    Liu X; Chong Y; Liu H; Han Y; Niu M
    J Ovarian Res; 2015 Jun; 8():35. PubMed ID: 26055813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
    Wang DY; Li N; Cui YL
    Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of CRM1 inhibits the nuclear export of p27(Kip1) phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer.
    Wang Y; Wang Y; Xiang J; Ji F; Deng Y; Tang C; Yang S; Xi Q; Liu R; Di W
    Cancer Lett; 2014 Feb; 343(1):6-13. PubMed ID: 24018641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-Box and Leucine-Rich Repeat Protein 20 (FBXL20), Negatively Regulated by microRNA (miR)-195-5p, Accelerates the Malignant Progression of Ovarian Cancer.
    Wu D; Liu C; Hong L
    Mol Biotechnol; 2021 Dec; 63(12):1235-1243. PubMed ID: 34338995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
    Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
    Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA PVT1-mediated miR-543/SERPINI1 axis plays a key role in the regulatory mechanism of ovarian cancer.
    Qu C; Dai C; Guo Y; Qin R; Liu J
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32441301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA GIHCG promotes development of ovarian cancer by regulating microRNA-429.
    Yao N; Yu L; Zhu B; Gan HY; Guo BQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8127-8134. PubMed ID: 30556850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function.
    Knauer SK; Bier C; Habtemichael N; Stauber RH
    EMBO Rep; 2006 Dec; 7(12):1259-65. PubMed ID: 17099693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of RNAi-mediated survivin gene silencing on apoptosis of ovarian cancer cell lines SKOV3 and SKOV3/ADM].
    Deng KX; Zhong L; Jiang MX; Chen WX; Chen Y; He H
    Ai Zheng; 2005 Aug; 24(8):945-50. PubMed ID: 16086871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
    Hao T; Huang S; Han F
    Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non‑coding RNA NEAT1 modifies cell proliferation, colony formation, apoptosis, migration and invasion via the miR‑4500/BZW1 axis in ovarian cancer.
    Xu H; Sun X; Huang Y; Si Q; Li M
    Mol Med Rep; 2020 Oct; 22(4):3347-3357. PubMed ID: 32945505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis.
    Xie W; Zhang L; Shen J; Lai F; Han W; Liu X
    BMC Cancer; 2024 May; 24(1):551. PubMed ID: 38693472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of CRM1 activity sensitizes endometrial and ovarian cell lines to TRAIL-induced cell death.
    Fabi F; Adam P; Vincent K; Demontigny F; Parent S; Joncas FH; Asselin E
    Cell Commun Signal; 2018 Jul; 16(1):39. PubMed ID: 29973205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of PTCH1 on Ovarian Cancer Cell Proliferation and Apoptosis.
    Zheng F; Xiao X; Wang C
    Cancer Biother Radiopharm; 2019 Mar; 34(2):103-109. PubMed ID: 30523702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation.
    van der Watt PJ; Maske CP; Hendricks DT; Parker MI; Denny L; Govender D; Birrer MJ; Leaner VD
    Int J Cancer; 2009 Apr; 124(8):1829-40. PubMed ID: 19117056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of survivin siRNA on growth, apoptosis and chemosensitivity of ovarian cancer cells SKOV3/DDP].
    Zhang X; Li N; Wang YH; Huang Y; Xu NZ; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):174-7. PubMed ID: 19615253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway.
    Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H
    Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy.
    Gao W; Lu C; Chen L; Keohavong P
    J Thorac Oncol; 2015 May; 10(5):815-825. PubMed ID: 25629636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.